Loading asset research
Lakewood-Amedex Biotherapeutics Inc. Common Stock
LABTNasdaq · USD · StocksQuote as of · Exchange session not verified$2.22
+8.29%
Today
LABT
Loading 1D prices…
Market cap
$5.3M
Volume
141K
52w high
$98.2052w low
$1.66Company profile
Lakewood-Amedex Biotherapeutics Inc. Common Stock
Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
University Park, FL, United States
Employees
5
Fiscal year end
1231
CIK
2079272
Session & valuation
Open$2.11
Previous close$2.05
Day high$2.23
Day low$2.03
30-day avg. volume902.4K
Outstanding shares2.4M
Diluted EPS-$2.76
Latest annual period
P/E (trailing)-0.80
P/E (forward)—
Price / book1.11
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PULMPulmatrix Inc. Common Stock | $5.1M | $0.00 | — | -$1.41 | -3.42% | Unrated |
| NCNANuCana plc American Depositary Share | $5.5M | — | — | $0.00 | -1.49% | Unrated |
| CANFCan-Fite Biopharma Ltd American Depositary Shares each representing two (2) Ordinary Shares | $5M | $405K | -2426.67% | -$5.97 | +9.72% | Buy |
| GLMDGalmed Pharmaceuticals Ltd. Ordinary Shares | $4.9M | $0.00 | — | $2.39 | -4.71% | Hold |
| ERNAErnexa Therapeutics Inc. Common Stock | $4.9M | $0.00 | — | -$2.24 | +3.73% | Buy |